Introduction
Protein N e -acetylation consists of the transfer of an acetyl moiety from an acetyl coenzyme A to the e-amino group of a lysine residue. This modification was first identified on histones in the 1960s by Allfrey et al. (1964) who proposed that it could 'influence RNA synthesis.' Forty years later, it has become clear that lysine acetylation can target many cellular proteins in addition to histones. Similarly to phosphorylation, methylation or ubiquitination, lysine acetylation belongs to the panel of posttranslational modifications used by the cell to alter the specific properties of a given protein (Kouzarides, 2000; Yang, 2005; Yang and Gregoire, 2005) . Lysine acetylation is a dynamic, reversible and tightly regulated protein modification. In vivo, acetylation is controlled by the antagonistic activities of acetyltransferases and deacetylases. Because acetylation was originally characterized on histones, lysine acetyltransferases and deacetylases are known as histone acetyltransferases (HATs) and histone deacetylases (HDACs).
Eukaryotic HDACs are divided into two groups based on the specificities of their catalytic mechanism. Group I HDACs are zinc-dependent amidohydrolases. Eleven subtypes have been identified and named chronologically HDAC1-11. While they share some degree of homology in their catalytic domain, group I HDACs are further subdivided into class I and class II enzymes on the basis of phylogenetic and structural criteria (Gregoretti et al., 2004) . HDAC1, the founding member of class I, shows a high degree of sequence similarity with the yeast transcriptional regulator Rpd3 (Rundlett et al., 1996; Taunton et al., 1996) . Together with HDAC1, four additional human Rpd3 orthologs, HDAC2, -3, -8 and -11 make up the mammalian class I HDAC family (Marks et al., 2003) . Class II HDACs (HDAC4, are defined based on their sequence homology with Hda1 in Saccharomyces cerevisiae (Fischle et al., 1999 (Fischle et al., , 2001 (Fischle et al., , 2002 Grozinger et al., 1999; Miska et al., 1999; Verdel and Khochbin, 1999; Wang et al., 1999; Kao et al., 2000; Zhou et al., 2001; Guardiola and Yao, 2002; Tong et al., 2002; Petrie et al., 2003) . The Hda1-like sequences of class II HDACs correspond to their catalytic domain. These enzymes also contain additional domains that allow for further subdivision into class IIa (HDAC4, and class . Recently, analysis of the silent information regulator (Sir2) protein in yeast and its homologues in higher eukaryotes (SirT1-7) has revealed a nicotinamide adenine dinucleotide NAD þ -dependent HDAC activity. Because of the obvious differences in their catalytic mechanism and their unrelated sequences, SirT proteins constitute the second group of mammalian HDACs often referred as class III enzymes (Haigis and Guarente, 2006) . This review is restricted to class IIa HDACs and will focus on the latest developments in the understanding of their regulation and biology. For more general information on HDACs, we respectfully refer the reader to previous excellent reviews from our colleagues (Bertos et al., 2001; Grozinger and Schreiber, 2002; de Ruijter et al., 2003; Legube and Trouche, 2003; Marks et al., 2003; Thiagalingam et al., 2003; Verdin et al., 2003; Yang and Seto, 2003; Blander and Guarente, 2004; Marmorstein, 2004; North and Verdin, 2004; Sengupta and Seto, 2004; Ekwall, 2005; Glozak et al., 2005; Nusinzon and Horvath, 2005; Yang and Gregoire, 2005) .
Structure of class IIa HDACs: the C-terminal deacetylase domain
HDAC4, -5, -7 and -9 are defined by their particular bipartite structure (Figure 1a ). The so-called HDAC domain is limited to a 400-450 amino acid region located at their C terminus. This region, which shows the highest homology to yeast Hda1 (52, 53, 51 and 51% similarity for HDAC4, -5, -7 and -9, respectively) is highly conserved among class IIa members (around 80% sequence similarity). Structural analysis of FB188 HDAH, a bacterial HDAC-like protein with significant homology to the catalytic domain of class II HDACs, has revealed that while the canonical fold of their catalytic pocket is very similar, there are several important differences between class I and class II HDACs that mainly concern the entrance region of the active site cavity and the outer charge transfer relay system (Finnin et al., 1999; Somoza et al., 2004; Vannini et al., 2004; Nielsen et al., 2005) . This might explain why, in contrast to class I HDACs, researchers in the field have remained remarkably unsuccessful at obtaining enzymatically active class IIa HDACs in recombinant forms in vitro (Hassig et al., 1998; Hu et al., 2000) . When successful, these attempts have mainly yielded protein preparations with low specific activity, especially when compared to the corresponding protein analysed in vivo (Wang et al., 1999) . Indeed, when expressed as an isolated subdomain the C-terminal region of class IIa HDACs associates with full-HDAC activity in vivo (Wang et al., 1999; Fischle et al., 2001 Fischle et al., , 2002 . Therefore, cumbersome transient transfection approaches followed by immunopurification have been required to measure significant deacetylase activity associated with class IIa HDACs . This suggests that the enzymatic activity of class IIa members would rely on For each protein, the longest isoform is shown, with the total number of residues and the corresponding database accession number. The CtBP, MEF2 and HP1-binding regions along with the NES and NLS are depicted as solid boxes. 14-3-3 binding sites are indicated with an S. NES, nuclear export signal; NLS, nuclear localization signal. (b) Identification of posttranslational modifications sites in the adapter domain of class IIa HDACs. Sequence corresponding to the N-terminal regions of HDAC4, -5, -7 and -9 were examined for the presence of 14-3-3 binding motifs (mode I and mode II), Dirk1 phosphorylation target sequence, sumoylation consensus and caspase 3 and 8 cleavage sites. For each identified motif, the position of the critical residue is indicated. Motifs are written in bold when the corresponding posttranslation modification was demonstrated experimentally.
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Class IIa histone deacetylases M Martin et al cellular cofactors or specific posttranslational modifications. Accordingly, there is evidence indicating that HDAC activity of class IIa members is dependent on an HDAC3/N-CoR/SMRT complex (Fischle et al., 2001 (Fischle et al., , 2002 . Related to this, HDAC4 was shown to be sumoylated at lysine 559 (Kirsh et al., 2002) . Because a K559R mutation abolished HDAC4-associated HDAC activity, the authors concluded that sumoylation was necessary for full enzymatic activity. However, binding of the K559R HDAC4 mutant to the N-CoR/ SMRT/HDAC3 complex was not investigated in the study. Therefore, it cannot be formally excluded that the effect on the enzymatic activity was due to an overall alteration of the protein structure resulting in an inability to associate with the active HDAC3 complex. All these remaining questions illustrate the fact that further efforts should be dedicated to understanding how the activity of class IIa HDACs is controlled in vivo.
Structure of class IIa HDACs: the N-terminal adapter domain
In addition to their Hda1-like domain, class IIa HDACs are comprised of a 450-600 amino acid extension at their N terminus. Overall, the sequence homology between the members of the family in this region is much lower (30-45%) than that of the HDAC domain. Nevertheless, this region contains conserved amino acid motifs that are specialized for binding an array of proteins. Most of these are DNA-binding transcription factors, for which class IIa HDACs serve as transcriptional corepressors (Table 1) . By far the best characterized of such interactions is the association with the MEF2 transcription factors which occurs via a 17 amino acid motif conserved in all class IIa HDACs (Verdel and Khochbin, 1999; Wang et al., 1999; Lu et al., 2000b; Kao et al., 2001; Dequiedt et al., 2003; Han et al., 2005) . Repression of MEF2-targeted promoters via recruitment of class IIa-associated HDAC activity has been extensively documented Wang et al., 1999; Lemercier et al., 2000; Lu et al., 2000b) and plays a key role in the biological functions of these enzymes (see below). Some interactions that take place in the N-terminal region of class IIa HDACs mediate the recruitment of their deacetylase activity into higherorder complexes, together with multiple other enzymes. Two examples of such interactions are interactions with C-terminal-binding protein (CtBP) and heterochromatin P1 (HP1). A 100 amino acid motif has been implicated in the interaction of HDAC4 and HDAC5 with HP1a and associated histone methyltransferase (HMTase) SUV39H1 (Zhang et al., 2002b) . The functional significance of the association between class IIa HDACs and HMTases remains unclear. However, considering that lysine deacetylation is a prerequisite to methylation, two attractive models emerge. First, this interaction would allow the recruitment of a deacetylase/methyltransferase complex that would be important for the establishment and maintenance of transcriptional Sparrow et al., 1999; Verdel and Khochbin, 1999; Wang et al., 1999; Lemercier et al., 2000; Lu et al., 2000a, b; Dressel et al., 2001; Kao et al., 2001 ) NF-AT3C DNA-anchoring transcriptional factor (Dai et al., 2005) DnaJ ( (Zhang et al., 2002b) . Alternatively, when bound to methylated histones, the HP1/HMTase complex could propagate a repressive chromatin state through class IIa HDACmediated deacetylation and subsequent methylation of adjacent nucleosomal histone tails. On a similar vein, the N terminus of HDAC4, -5 and -9 comprises an interaction motif for the transcriptional corepressor CtBP (Dressel et al., 2001; Zhang et al., 2001a) . Since CtBP is part of a higher-order complex containing chromatin-modifying enzymes such as class I HDACs and HMTs (Shi et al., 2003) , it is tempting to speculate that class IIa HDACs might use CtBP to recruit multiple enzymatic activities to their target promoters. The adapter domain of class IIa HDACs also contains motifs specifically involved in their regulation. Three clusters of arginine/lysine residues are found between aa 251-272 of HDAC4 and aa 264-285 of HDAC5. Mutational analyses confirmed the ability of these sequences to act as an autonomous nuclear import signal and enlightened their importance in the subcellular localization of HDAC4 and HDAC5 Wang and Yang, 2001) . Despite the lack of experimental evidence, it is likely that this nuclear localization signal (NLS) also mediates the observed interaction between HDAC4 and importina (Grozinger and Schreiber, 2000) . These motifs are fairly well conserved in HDAC7 and HDAC9 and although it has not been formally demonstrated, it is logical to assume that the corresponding regions constitute authentic nuclear import signals for these class IIa members.
A puzzling feature of the N-terminal adapter domain of class IIa HDACs is its ability to inhibit transcription when tethered to a heterologous promoter, independently of the C-terminal catalytic domain (Sparrow et al., 1999; Wang et al., 1999; Zhou et al., 2000b) . This property has been assigned to a glutamine-rich domain (aa 69-155 of HDAC4 that contains 26 glutamine residues), which organizes into a single a-helix and would be involved in homo-and/or hetero-oligomeric protein-protein interactions (Kirsh et al., 2002; Guo et al., 2007) . Curiously, this region, which is conserved in HDAC4, -5 and -9, is not present in HDAC7. To date, very few experiments have been conducted to understand how the coiled-coil domain of HDAC4, -5 and -9 might repress transcription. Resolution of this question must await the identification of the cellular factors interacting specifically with this region.
The adapter domain of class IIa HDACs contains specific residues that are subjected to various posttranslational modifications, such as proteolytic cleavage (Bakin and Jung, 2004; Liu et al., 2004; Paroni et al., 2004) , ubiquitination , sumoylation (Kirsh et al., 2002; Petrie et al., 2003) and most importantly phosphorylation. In response to various stimuli, a set of serine residues in the adapter domain of class IIa HDACs is phosphorylated, creating docking sites for the 14-3-3 proteins (Grozinger and Schreiber, 2000; Wang et al., 2000) . Association with 14-3-3 induces nuclear export and cytoplasmic accumulation of class IIa HDACs with concomitant derepression of their target promoters (Grozinger and Schreiber, 2000; Wang et al., 2000; Kao et al., 2001; Liu et al., 2005) . This nuclear export mechanism allows for signaldependent activation of class IIa HDAC target genes and has proven to be crucial for their regulation (see below). The 14-3-3 proteins are a highly conserved family of proteins that have important roles in a wide range of cell signaling pathways (Dougherty and Morrison, 2004; Mackintosh, 2004) . They bind to specific phosphoserine-or phosphothreonine-containing motifs within target proteins that generally match with either RxxpSxP (mode I) or RxxxpSxP (mode II) (Muslin et al., 1996) . Their rigid structure and dimeric nature allow them to act as intra-and intermolecular adapters and to alter specific properties of their target proteins (Yaffe, 2002 Class IIa histone deacetylases M Martin et al these serine residues into alanines totally abolished interaction between HDAC5/9 and 14-3-3 Zhang et al., 2002a) . Unexpectedly, the corresponding serine-to-alanine double mutants of HDAC4 and HDAC7 retained residual 14-3-3 binding (McKinsey et al., 2000a, b; Wang et al., 2000; Kao et al., 2001) . This observation led to the identification of Ser 632 in HDAC4 and Ser 449 in HDAC7 as additional 14-3-3 binding sites (Grozinger and Schreiber, 2000; McKinsey et al., 2000a; Wang et al., 2000; Kao et al., 2001; Dequiedt et al., 2003) . Surprisingly, the corresponding motif is also conserved in HDAC5 and -9 ( Figure 1b ). In addition, we recently identified a cryptic 14-3-3 binding site (Ser 181 ) in HDAC7 (Dequiedt et al., 2005 (Dequiedt et al., , 2006 . This site was overlooked in previous mutational analyses because its phosphorylation seems dependent on prior phosphorylation of the most N-terminal serine residue, Ser
155
. Whereas Ser 181 is uniquely present in HDAC7, sequence analyses disclosed other putative cryptic 14-3-3 motifs in the adapter domain of HDAC4, -5 and -9 ( Figure 1b) . The functionality and possible biological relevance of these additional sites should be investigated comprehensively.
Functions of class IIa HDACs
Corepressors of transcription Class IIa HDACs are thought to act as transcriptional corepressors by deacetylating nucleosomal histones. Since these enzymes do not bind directly to DNA, the current model posits that their deacetylase activity is recruited to specific promoters by sequence-specific DNA-binding proteins. Interactions with distinct transcription factors would thus dictate targeting specificity of class IIa HDACs. The canonical example of this model is illustrated by the interaction between class IIa HDACs and MEF2 transcription factors.
Historically, MEF2 was the first cellular partner identified for class IIa HDACs Sparrow et al., 1999; Wang et al., 1999; Lemercier et al., 2000; Lu et al., 2000b) . The MEF2 family consists of four MADS-box transcription factors (MEF2A, -B, -C and -D) involved in numerous signal-dependent pathways of cellular differentiation (Black and Olson, 1998) . Members of the MEF2 family can act as repressors or activators of transcription depending on the mutually exclusive recruitment of specific chromatin-modifying factors (Youn et al., 2000; McKinsey et al., 2001a) . MEF2 associates with class IIa HDACs through a region located at the junction of the MADS/MEF2 domain, which does not overlap with the DNA-binding region of MEF2 (Lu et al., 2000b) . This and other observations are compatible with a simple model in which, through interaction with the N terminus of class IIa HDACs, DNA-bound MEF2 would recruits the HDAC activity associated with their C termini to deacetylate local chromatin and repress transcription. This would establish class IIa HDACs as general transcriptional repressors of the multitude of promoters that are under the control of MEF2 transcription factors (McKinsey et al., 2002) . Accordingly, the ability of class IIa HDACs to act as potent inhibitors of MEF2-dependent transcription has been extensively documented Sparrow et al., 1999; Wang et al., 1999; Lemercier et al., 2000; Lu et al., 2000b; Dressel et al., 2001) . Several experimental observations suggest that class IIa HDACs might control MEF2 transcriptional activity through additional mechanisms. MEF2-interacting transcription repressor (MITR), a splice variant of HDAC9 that comprises only the N-terminal adapter domain efficiently impairs MEF2-dependent transcription (Zhou et al., 2000a; Zhang et al., 2001b) . Therefore, in addition to the HDAC activity associated with their C terminus, class IIa HDACs might also repress MEF2 transcriptional activity through association of their N-terminal domain with corepressors such as HP1 or CtBP (Zhang et al., , b, 2002a . Recently, HDAC4 and -5 were shown to promote sumoylation of MEF2, which results in inhibition of its transcriptional activity Zhao et al., 2005; Gregoire et al., 2006) . As opposed to the original model, these results illustrate the multiple levels of regulation of MEF2 by class IIa HDACs and emphasize the need for further work to achieve comprehensive understanding of these mechanisms (Figure 2 ).
Members of the nuclear factor of activated T cells (NFAT) family of transcription factors play prominent roles as regulators of calcium-inducible gene expression in diverse cell types (Hogan et al., 2003) . A recent study indicated that class IIa HDACs interact with NF-AT3c to repress its transcriptional activity (Dai et al., 2005) . In contrast to the interaction with MEF2, the recruitment of class IIa HDACs by NFAT is indirect and relies on a bridging cofactor, the chaperone mammalian relative of DnaJ (Mrj). However, the biological relevance underlying NFAT transcriptional repression through Mrj and class IIa HDACs remains obscure.
Members of the Runx family of transcription factors have important functions in several developmental Class IIa histone deacetylases M Martin et al programs (Otto et al., 2003) . Runx1 is involved in hematopoietic development and mice deficient in Runx2 display alterations in bone development (Komori et al., 1997; Otto et al., 1997 (Vega et al., 2004b) . Accordingly, reduced histone acetylation of a Runx2 target promoter was observed following overexpression of HDAC4. However, rather than the classical model in which Runx2 would tether HDAC4 to DNA to deacetylate nucleosomal histones, the authors of the study provided evidence that HDAC4 interferes with the ability of Runx2 to bind to its target promoter. In preosteoblasts, HDAC4 and -5 regulate Runx2 activity to control osteoblast differentiation. In this case, the repression of Runx2 activity may rely on the recruitment of class IIa HDACs to Runx2 target promoters through interaction with Smad3 (Kang et al., 2005) . Finally, HDAC4 and -5 were reported to directly deacetylate Runx2 and Runx3 which would lead to their ubiquitin-mediated degradation and repression of their transactivation activity (Jin et al., 2004; Jeon et al., 2006) . Interestingly, the model that emerges from these observations is dramatically different from what has been established for the regulation of MEF2. While in some instance, class IIa HDACs would act as corepressors of Runx-dependent transcription by promoting local deacetylation of histones, they may also inhibit Runx activity by hindering its DNA-binding abilities and by promoting its deacetylation-mediated degradation. Deacetylation of Runx2 by HDAC4/5 reinforces the accumulating evidence suggesting that class IIa HDACs might also target nonhistone proteins for deacetylation. During the past few years, class IIa HDACs have been shown to repress an increasing number of transcriptional regulators through direct or indirect interaction. Interestingly, many of these are important regulators of key genetic programs during development, such as members of the GATA (Ozawa et al., 2001; Watamoto et al., 2003) , Forkhead (Li et al., 2007) , NK-2 homeodomain-containing and signal transducer and activator of transcription (Xiao et al., 2003) families of transcription factors.
Unfortunately, for the majority, these interactions remain as yet mechanistically and functionally poorly characterized. Future studies will hopefully shed some light on these interesting issues.
Class IIa HDACs are also candidates for cooperation and regulation of the members of the nuclear hormone receptor family. As a general mechanism, the conserved zinc finger DNA-binding domain of nuclear receptors shows ability to interact with HDAC4 (Franco et al., 2003) . At least in the case of TR2, this interaction is of functional consequence as the recruitment of HDAC4 leads to a reduction of acetylated histone associated with a TR2-related promoter. More recently, a study identified HDAC7 as a novel corepressor of the androgen receptor (AR) (Karvonen et al., 2006) . Class IIa HDACs also interact with RIP140, REA and ARR19, three transcriptional regulators recruited by the nuclear estrogen receptor for the first two, and by the AR for the latter, respectively (Castet et al., 2004; Jeong et al., 2004; Kurtev et al., 2004) .
Interestingly, among the proteins interacting with class IIa HDACs, several contain ankyrin-repeat regions, indicating that similar structural determinants mediate association of class IIa HDACs with these transcription factors. Hence, class IIa HDACs interact with and repress the transcriptional activity of regulatory factor X-associated ankyrin-containing protein (RFXANK), a positive regulator of MHC II genes expression McKinsey et al., 2006) ; of ANCO 1, a nuclear receptor cofactor ; of B-CoR and B-CoR L1 (Huynh et al., 2000; Pagan et al., 2007) and calmodulin-binding transcription activator (CAMTA) . Class IIa HDACs also interact with ANKRA, a protein related to RFXANK, but the functional implications of this interaction are unknown McKinsey et al., 2006) .
Atypical roles
As transcriptional coactivators of HIF-1a Recent findings show that general HDAC inhibition may not only lead to gene activation but also to gene repression (Glaser et al., 2003; Nusinzon and Horvath, 2005) . Supporting this in the case of class IIa HDACs, the C terminus of HDAC4 and -7 but not HDAC5 has been shown to bind to hypoxia-inducible factor 1a (HIF-1a), a transcription factor that controls expression of genes responsive to low oxygen tension. Surprisingly, association with HDAC7 leads to increased HIF-1a transcriptional activity under hypoxic conditions (Kato et al., 2004) . The exact mechanism underlying the transcriptional activation of HIF-1a by some members of class IIa HDACs remained unclear until recently, when it was reported that inhibition of HDAC4 by small interfering RNA had a positive effect on HIF-1a acetylation, which correlated with reduced stability (Qian et al., 2006) .
As SUMO E3 ligases In addition to being sumoylated, HDAC4, and potentially other class IIa members can act as small ubiquitin-like modifier (SUMO) E3 ligases, a property dependent on their N-terminal domain Zhao et al., 2005; Gregoire et al., 2006) . Interestingly, MEF2 was identified as a relevant target for this novel class IIa-associated enzymatic activity. HDAC4 promoted sumoylation of MEF2 that inhibits its transcriptional activity. However, whether this effect is indirect or results from an intrinsic SUMO-ligase activity of HDAC4 is still a matter of debate (Gregoire et al., 2006) .
HDAC4 as a component of the DNA damage response pathway Given the recent interaction unraveled
Class IIa histone deacetylases M Martin et al between HDAC4 and the repair factor 53BP1, HDAC4 was thought to be a component of the DNA damage response . Indeed, in response to DNA damage, HDAC4 is recruited to the same dots, or repair foci, together with 53BP1. Moreover, silencing of HDAC4 abrogates DNA damage-induced G 2 delay and increases radiosensitivity. Because drugs that inhibit transcription do not reverse these effects, the role of HDAC4 in DNA damage response is likely not restricted to transcriptional repression. Two recent studies shed new light on this mechanism by showing the DNA damage-dependent recruitment of HDAC4 by a repressor complex containing P53 and NF-Y, a complex that is involved in the repression of G 2 /M promoters (Imbriano et al., 2005; Basile et al., 2006) . HDAC7 as a mitochondrial protein implicated in programmed cell death Sequence analysis identified a mitochondrial targeting motif in the N-terminal domain of human HDAC7 (Bakin and Jung, 2004) . This motif targets HDAC7 to the mitochondria where it is N terminally processed and can be located in the mitochondrial inner membrane space. The fact that HDAC7, like other proapoptotic mitochondrial factors, relocalizes to the cytoplasm in response to apoptosis points to a possible role in the initiation of programmed cell death. However, no additional experimental data is currently available to strengthen the significance of mitochondrial HDAC7 in the process of apoptosis.
Regulation of class IIa HDACs
Subcellular distribution
As expected from their ability to deacetylate histones, class IIa HDACs are found in the nucleus of most cell lines. However, depending on cell lines examined, a significant portion of the molecules can also be found in the cytoplasm, suggesting that these enzymes may shuttle between the nucleus and the cytoplasm Fischle et al., 2001) . Early confocal microscopy experiments with leptomycin B and recently using the fluorescence loss in photobleaching technology confirmed that class IIa HDACs are subject to CRM1-dependent nuclear export Grozinger and Schreiber, 2000; Wang et al., 2000; Kao et al., 2001; Dequiedt et al., 2006) . Cytoplasmic accumulation of class IIa HDACs renders them unable to impact on transcription since it sequesters them away from their histone substrates and renders them enzymatically inactive as HDACs (Fischle et al., 2001 (Fischle et al., , 2002 . The nucleocytoplasmic distribution of class IIa HDACs is controlled by two separate domains: an NLS present in the N-terminal adapter domain of all class IIa HDACs and a nuclear export signal (NES) in the C-terminal part McKinsey et al., 2001b) . This property of class IIa HDACs has attracted a lot of attention in the past few years and has emerged as a major mechanism in the regulation of these enzymes.
Relocalization of class IIa HDACs to more specific subcellular compartments or structures could also participate in the regulation of class IIa HDACs. It was proposed that mitochondrial targeting and processing of HDAC7 may act as an irreversible intracellular reservoir to sequester HDAC7, which would otherwise be available for nucleocytoplasmic trafficking (Bakin and Jung, 2004) . Class IIa HDACs can localize into specific subnuclear structures and HDAC5 has been found to form dot-like nuclear structures, termed matrix-associated deacetylase bodies Wang et al., 1999; Downes et al., 2000; McKinsey et al., 2000b) . In response to DNA damage, HDAC4 is recruited to nuclear repair foci, together with the DNA damage response protein 53BP1 . Additionally, ICP0, a protein encoded by the herpes simplex virus 1, has been shown to colocalize with and to promote the nuclear redistribution, in ring-shaped structures, of class IIa HDACs (Lomonte et al., 2004) .
Phosphorylation of 14-3-3 binding sites Several lines of evidence suggest that phosphorylation of their 14-3-3 sites regulates subcellular localization of class IIa HDACs. Inhibition of class IIa HDAC phosphorylation, by protein kinase inhibitors or serine-to-alanine mutation of the 14-3-3 consensus sites, leads to their nuclear accumulation. In contrast, activation of phosphorylation by overexpression of protein kinases leads to cytoplasmic accumulation of class IIa HDACs.
To date, four families of class IIa HDAC kinases have been identified (Figure 3) . Historically, members of the Ca 2 þ /calmodulin-dependent kinase family (CaMK), specifically CaMKI and IV, were the first kinases shown to promote nuclear export of class IIa HDACs. Phosphorylation of HDAC4 is illustrated as an example as it is the only class IIa member phosphorylated by CaMKII. CaMKI and CaMKIV show a moderate preference for the most N-terminal site, whereas CaMKII exhibits some specificity for the internal site. PKD can phosphorylate indiscriminately the three 14-3-3 binding sites. In contrast, MARK selectively targets the most upstream serine residue. The two most N-terminal sites are optimal recognition motifs for SIK1 and are efficiently phosphorylated by this kinase. (Berdeaux et al., 2007) . The existence of multiple families of kinases targeting class IIa HDACs, each with multiple isoforms, reflects the numerous biological roles of these transcriptional repressors. This diversity allows class IIa HDACs to respond to different signaling pathways, with each signaling pathway providing a functional relevance for a given kinase. Some kinases have been shown to act preferentially on specific members of the class IIa family, which emphasizes the importance that distinct class IIa HDACs may have in specific genetic programs (Chawla et al., 2003; Liu et al., 2005; . CaMKII, for example, is able to drive HDAC4, but not HDAC5, out of the nucleus, probably because HDAC4 possesses a nonconserved CaMKII-binding site (Backs et al., 2006) . Some class IIa HDAC kinases may display preferences toward specific 14-3-3 sites. In vitro, PKD is much less effective at phosphorylating Ser 259 than Ser 498 of HDAC5 (Huynh and McKinsey, 2006) . In contrast, MARK2 and -3 were shown to uniquely phosphorylate Ser 155 but not other 14-3-3 sites of HDAC7 (Dequiedt et al., 2006) . CaMKI and -II target different sites in HDAC4 . These differences suggest that phosphorylation of each 14-3-3 site may have a specific impact on the regulation of class IIa HDACs and that multisite phosphorylation by distinct protein kinases may constitute a tightly regulated mechanism to induce expression of specific target genes in response to specific signals (Figure 3) .
Dephosphorylation at the 14-3-3 binding sites It is logical to envision the phosphorylation-dependent regulation of class IIa HDACs as a reversible mechanism. In this context, relocalization of class IIa HDACs to the nucleus and reinstatement of their transcriptional inhibition would be expected to occur through dephosphorylation by a cellular phosphatase (Figure 4 ). Supporting this idea, calyculin A, an inhibitor of protein phosphatases PP1 and PP2A, has been shown to promote cytoplasmic retention of HDAC4 and to reduce its interaction with importina (Grozinger and Schreiber, 2000) .
Until recently, the identity of such an activating class IIa HDAC phosphatase was still an open question. A very recent study showed that, few hours after its signal-dependent nuclear export, HDAC7 becomes dephosphorylated and reenters the nucleus. Myosin phosphatase, containing PP1b and myosin phosphatase targeting subunit 1, was identified as an HDAC7-associated complex. This complex seems able to dephosphorylate the 14-3-3 binding sites of HDAC7 and promote its nuclear localization after signal-dependent export (Parra et al., 2007) . In addition, results from our laboratory reveal that another cellular phosphatase, PP2A, stably associates with the N-terminal domain of class IIa HDACs. Our observations demonstrate that PP2A constitutively dephosphorylates class IIa HDACs in vivo and regulates their subcellular localization and repressor activity, thereby controlling their biological functions (Martin and Dequiedt, manuscript submitted) . The identification of multiple class IIa HDAC phosphatases may signify that class IIa HDACs dephosphorylation is regulated by different signaling pathways and would allow for flexible control of class IIa HDAC functions. Sequential or coordinated actions of the various protein kinases and phosphatases on the N terminus of class IIa HDACs would constitute a tightly regulated mechanism to rapidly, appropriately and reversibly induce expression of specific target genes in response to specific signals.
Association with 14-3-3 and other cellular proteins Association with 14-3-3 proteins soon appeared as a critical factor in the regulation of class IIa HDAC subcellular localization (Grozinger and Schreiber, 2000;  Class IIa histone deacetylases M Martin et al McKinsey et al., 2000b; Wang et al., 2000; Kao et al., 2001) . As observed for most 14-3-3 binding partners (Muslin et al., 1996) , this association is dependent on the phosphorylation of interacting motifs within class IIa HDACs. 14-3-3 proteins are thought to regulate the subcellular localization of class IIa HDACs by modulating the function of their NES and NLS. First, binding of a 14-3-3 dimer would mask the N-terminal NLS and prevent class IIa HDAC recognition by importina (Grozinger and Schreiber, 2000) . Alternatively, binding of 14-3-3 proteins could unmask the C-terminal NES of class IIa HDACs or provide an NES in trans, facilitating nuclear export . It is thus well established that signal-dependent phosphorylation of the conserved serine residues and subsequent 14-3-3 binding are critical in the control of the subcellular localization of class IIa HDACs. However, it is still difficult to establish the precise sequence of events involved in this mechanism. Whether binding of 14-3-3 precedes and/or promotes nuclear export or whether it takes place in the cytoplasm and prevents nuclear import of class IIa HDACs remains unclear. Clues about this issue came from experiments using HDAC5 constructs harboring inactivated NES. These mutants are unable to exit the nucleus despite intact phosphorylation 14-3-3 binding sites. Importantly, these mutants cannot efficiently inhibit muscle differentiation, indicating that release from their targeting DNA-binding factor is the crucial step in the relief of their transcriptional repression McKinsey et al., 2000a) . In this context, 14-3-3-dependent nuclear export of class IIa HDACs may serve as a supporting mechanism to ensure maximal activation of their target genes . Interestingly, the fact that 14-3-3 proteins are also regulated by phosphorylation may provide an additional level of regulation of class IIa HDAC nucleocytoplasmic shuttling (Fu et al., 2000; Tzivion and Avruch, 2002; Ellis et al., 2003; Shen et al., 2003) .
In addition to 14-3-3 proteins, the subcellular localization and repressor activity of class IIa HDACs are controlled by additional cellular factors. The nuclear export of class IIa HDACs is inhibited by leptomycin B, which suggests that the export receptor CRM1 may interact with the leucine-rich NES found in class IIa HDACs Harrison et al., 2004) . Whereas no CRM1 class IIa HDACs association has ever been formally documented, overexpression of CRM1 promotes cytoplasmic accumulation of HDAC7 .
Overexpression of MEF2 was reported to promote nuclear localization of class IIa HDACs. While direct interaction between both proteins was required for nuclear targeting of class IIa HDACs, no experiment HDACs is associated with displacement from their target promoters, association with 14-3-3 proteins and nuclear export through a CRM1-dependent pathway. This depletes the nuclear compartment of class IIa HDACs and allows for expression of a specific set of target genes. Importation of class IIa HDACs to the nucleus and reinstatement of their transcriptional inhibition is achieved through dissociation from 14-3-3 proteins (by a still unknown mechanism) and dephosphorylation by cellular phosphatase such as PP2A or myosin phosphatase. In the cytoplasm, dephosphorylated class IIa HDACs may be more sensitive to ubiquitin-mediated proteolytic degradation.
Class IIa histone deacetylases M Martin et al was conducted to explain the underlying mechanism Borghi et al., 2001; Wang and Yang, 2001; Chan et al., 2003) .
Signaling
Multiple signaling pathways impact on class IIa HDAC localization, the effects of which can most of the time be attributed to the activation of one or more class IIa HDACs protein kinases. In agreement with this, class IIa HDAC mutants in their phosphorylatable serine residues remain nuclear and are thus effective blockers of related developmental programs.
Agonists that stimulate PKD, through PKC-dependent or -independent mechanisms, induce class IIa HDAC phosphorylation and nuclear export. This is the case for the PKC activator phorbol 13-myristate 12-acetate, for the B-and T-cell receptors and for several other cell surface receptors, such as the serotonin receptor and the G protein-coupled receptors (GPCR) endothelin receptor, a 1 -AR and PGF2a. Signaling via Rho-guanosine triphosphates, mediators of GPCR signaling, and via phospholipase C, a mediator that lies downstream of a 1 -AR, also activates PKD and triggers phosphorylationdependent nuclear export of HDAC5 (Chang et al., 2005; Dequiedt et al., 2005; Harrison et al., 2006) . Some of these cell surface receptors also activate calcium fluxes and thus part of their effects could be mediated through activation of CaMKs . It has been shown that cardiac hypertrophic stimuli, such as pressure overload or expression of activated calcineurin, activate a cardiac kinase(s) that phosphorylates the regulatory serine residues within HDAC5 and HDAC9. However, the identity of this kinase remains unknown (Zhang et al., 2002a; Chang et al., 2004) .
Neuronal receptors involved in synaptic activity also regulate class IIa HDACs localization in a way that depends on the phosphorylatable serine residues. Whereas neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5 was induced through both L-type calcium channels and synaptic N-methyl-Daspartic acid receptors, differences in the activation thresholds for HDAC4 and HDAC5 nuclear export were observed (Chawla et al., 2003) . Another neuronal signaling pathway converges on class IIa HDACs. In cultured cerebellar granules, HDAC4 accumulates in the nucleus in response to death stimuli. Interestingly, this translocation can be prevented by a survival factor, the neurotrophin brain-derived neurotrophic growth factor (BDNF). Treatment with a CaMK inhibitor promoted HDAC5 nuclear translocation, even with BDNF treatment, suggesting that CaMK may be a downstream effector of BDNF in this signaling pathway. Accordingly, the BDNF receptor can activate phospholipase C, which can then produce a rise in intracellular calcium and activate CaMK . Of note, phospholipase C can also contribute to activate PKD. HDAC5 was reported to undergo similar nuclear translocation in response to low potassium, or to CaMK inhibition (Linseman et al., 2003) .
Besides the above examples, very few signals have been reported to induce nuclear import of class IIa HDACs. Heat shock stimulation induced HDAC4 nuclear translocation (Dai et al., 2005) , hypoxic conditions, in the presence of HIF-1a, drive HDAC7 to the nucleus (Kato et al., 2004) and hormone occupancy of the AR induces nuclear transfer of HDAC7 and -4 (Halkidou et al., 2004; Karvonen et al., 2006) . The mechanism by which these signals lead to class IIa HDACs nuclear accumulation is not known and undoubtedly deserves further investigation.
Other posttranslational modifications
In addition to their 14-3-3 binding sites, other class IIa HDAC residues are subject to phosphorylation. Dyrk1B phosphorylates HDAC5 at a serine residue shared by HDAC4 and HDAC9, but not by HDAC7. Phosphorylation by Dyrk1 reduces their nuclear accumulation and leads to MEF2 activation (Deng et al., 2005) . This residue does not correspond to a 14-3-3 binding site and its mutation does not prevent CaMK-induced nuclear export , but it lies within the nuclear localization region of class IIa HDACs. In contrast, oncogenic Ras was found to promote the nuclear localization of HDAC4 by stimulating its phosphorylation by extracellular signal-regulated kinase 1 and -2 (ERK1/2) (Zhou et al., 2000b) . However, no experiment demonstrated direct phosphorylation of HDAC4 by ERK1/2 nor identified the target residue(s).
HDAC4 and -9 are subject to sumoylation, at a lysine residue also conserved in HDAC5 (Tatham et al., 2001; Kirsh et al., 2002; Petrie et al., 2003) . SUMO is believed to alter the interaction properties of its target, often affecting its localization within the cell (Seeler and Dejean, 2001) . The functional relevance of class IIa HDAC sumoylation is still unclear, but sumoylation abolished HDAC4-associated HDAC activity (Kirsh et al., 2002) . Interestingly, indirect evidence suggests that class IIa HDAC sumoylation might be coordinated with phosphorylation. Indeed, by a still-unknown mechanism, two proteins involved in the process of sumoylation, the sumo-specific protease (SENP) 'SUMO remover' and protein inhibitor of activated STAT, an E3 ligase, promote phosphorylation of 14-3-3 binding sites of HDAC5 (Chang et al., 2005) . In addition, HDAC4 and HDAC7 are cleaved by caspases. In both cases, cleavage separates the N-terminal NLS from the C-terminal NES. Whereas the caspase-generated N-terminal fragment of HDAC4 retains repressor ability Paroni et al., 2004) , cleavage of HDAC7 abolishes its transcription repressor activity (F Scott and F Dequiedt, unpublished observations).
Biological functions of class IIa HDACs
As described above, class IIa HDACs interact with a wide array of transcription factors and could thus potentially control the plethora of genetic programs associated with every one of these DNA-binding transcriptional regulators. Surprisingly, most of the biological functions attributed to class IIa HDACs to Class IIa histone deacetylases M Martin et al date rely directly or indirectly on their interaction with the members of the MEF2 family of transcription factors. Specific MEF2 isoforms play important transcriptional regulatory roles in myogenesis (Black and Olson, 1998; McKinsey et al., 2002) , cardiac differentiation and metabolism (McKinsey et al., 2002) , neuronal differentiation and survival (Heidenreich and Linseman, 2004) , negative selection of thymocytes (Woronicz et al., 1994 (Woronicz et al., , 1995 and vascular development (Lin et al., 1998) .
Given the major role played by MEF2 factors in muscle gene regulation and the fact that all class IIa HDAC members are expressed in undifferentiated myoblasts (Dressel et al., 2001; Haberland et al., 2007) , it was logically hypothesized that MEF2 regulation by class IIa HDACs would be relevant to muscle differentiation. Indeed, early experiments showed that ectopic expression of HDAC4, -5 and -7 in myoblasts efficiently blocked their in vitro differentiation into myotubes (Lu et al., 2000b; Dressel et al., 2001) . Whereas no similar experiment has been reported for HDAC9, its MITR isoform displays antimyogenic activity in vitro . Surprisingly, mutant mice for each individual class IIa HDAC do not display an overt muscle phenotype. This unexpected observation might result from the functional redundancy between each member of the family.
Cardiac muscle cells adapt to specific stimuli such as stress or exercise by hypertrophic growth, which is associated with an increase in cell size and activation of a fetal cardiac gene program . MEF2 integrates many stress signals in the adult myocardium and regulates numerous fetal cardiac genes (McKinsey et al., 2002; Czubryt and Olson, 2004) . All class IIa members are detectable in mouse heart suggesting a functional role for the MEF2 class IIa HDACs axis in cardiac hypertrophy (Zhang et al., 2002a) . Indeed, expression of constitutively repressive mutants of HDAC4, -5 and -9 prevents hypertrophic gene expression in primary rat cardiomyocytes (Zhang et al., 2002a; Vega et al., 2004a; . In contrast, disruption of HDAC9 leads to hyperactivation of MEF2-dependent transcriptional activity in response to pathologic cardiac hypertrophic signals (Zhang et al., 2002a) . Accordingly, HDAC9 mutant mice show enhanced cardiac growth in response to pathologic signals and develop spontaneous cardiac hypertrophy with advancing age. Similar effects are observed in HDAC5 mutant mice. In addition, simultaneous deletion of HDAC5 and -9 led to embryonic and early postnatal death from dramatic cardiac abnormalities. These observations suggest important but redundant functions for HDAC5 and -9 in pathological cardiac hypertrophy (Chang et al., 2004) . Cardiac phenotypes associated with deletion of HDAC5 or HDAC9 may not be due solely to their ability to repress MEF2 transcriptional activity. Indeed, only a small fraction of the genes that are induced during cardiac hypertrophy are controlled by MEF2. Recently, CAMTA2, a member of the CAMTA family of transcription factors was identified as an additional target of HDAC5 and a crucial regulator of cardiac hypertrophy (Song et al., 2006) . Interestingly, HDAC5 associates with MEF2 and CAMTA2 through different regions of its N-terminal adapter domain, suggesting that class IIa HDACs may control cardiac hypertrophy by repressing simultaneously several key transcription factors. In this context, class IIa HDACs also repress genes regulated by serum response factor (SRF), another important myogenic factor. However, whether this inhibition is mediated through direct binding to SRF (Davis et al., 2003) or association with its coactivator myocardin (Xing et al., 2006) is still unclear. Moreover, recent evidence suggests that class IIa HDACs could participate in the transcriptional repression mediated by NSRF, another transcription factor that regulates the reactivation of fetal cardiac genes (Nakagawa et al., 2006) . Obviously, identification of additional targets of class IIa HDACs during cardiac hypertrophy remains an important question.
Mice lacking HDAC4 die early during the perinatal period due to accelerated chondrocyte hypertrophy leading to dramatic skeletal abnormalities. This phenotype establishes HDAC4 as a negative regulator of chondrocyte hypertrophy. The role of HDAC4 in bone development was originally thought to arise from its ability to repress the transcriptional activity of Runx2, a positive factor for chondrocyte hypertrophy (Vega et al., 2004b) . However, the recent identification of MEF2C as a prohypertrophic factor during endochondral bone development raised the possibility that at least some, if not most of the repressive effects of HDAC4 on bone development might be mediated by MEF2 . This hypothesis was validated by the observation that deletion of HDAC4 restored normal bone formation in heterozygous MEF2C mutant mice, and that deletion of a single MEF2C allele prevented the skeletal defects associated with the lack of HDAC4. Of note, expression of Runx2 was dramatically reduced in the endochondral cartilage of MEF2C mutant mice, suggesting that some of the defects observed in MEF2C mutant mice may be attributable to decreased expression of Runx2. Since other class IIa HDACs are not expressed in developing bones, the role of HDAC4 as a negative regulator of chondrocyte hypertrophy could be unique and specific.
In humans, HDAC7 shows a restricted expression pattern with highest expression in thymus, heart and lung. In thymus, we have shown that HDAC7 is transiently and predominantly expressed in CD4/CD8 double-positive thymocytes, which undergo negative selection, a process that ensures the removal of strongly self-reactive T cells. In CD4/CD8 double-positive thymocytes, HDAC7 associates with the MEF2 family member MEF2D, to repress expression of the proapoptotic gene nur77 . Strong TCR signals, such as those occurring in self-reactive T cells, would activate nur77 expression through dissociation of the MEF2D-HDAC7 interaction. Of note, whereas in vitro experiments showed that HDAC4 can associate with MEF2D in T cells (Youn et al., 2000) , its expression levels remain marginal in human CD4/CD8 double-positive thymocytes . Recently, in situ hybridization during mice embryogenesis unraveled specific expression of HDAC7 in developing vascular endothelium. Consistent with this, inactivation of the HDAC7 gene in a ubiquitous or endothelialspecific manner led to embryonic lethality resulting from blood vessel dilatations, rupture and hemorrhages . The vascular defects associated with HDAC7 deficiency could be, at least in part, attributed to the upregulation of matrix metalloprotease 10 (MMP-10), a secreted proteinase that degrades extracellular matrix. Indeed, MEF2C binds to the MMP-10 promoter and may therefore recruit HDAC7 to repress its transcriptional activity. Extensive analysis of other genes potentially regulated by HDAC7 in endothelial cells may not only contribute to a better understanding of vascular development but may also help in identifying potential MEF2-independent class IIa HDAC functions.
Therapeutic implications
During the past few years, the dedicated efforts of the Olson laboratory have been instrumental in establishing some important biological functions of class IIa HDACs in vivo. Strikingly, all these seemingly unrelated processes share the common characteristic of depending on the tight control of MEF2 transcriptional activity by class IIa HDACs. The fact that key processes such as formation of skeletal muscle, cardiac hypertophy, bone development, T-cell differentiation and neuronal survival are controlled by class IIa HDACs suggests possibilities for therapeutical intervention in numerous human pathologies. Endothelial cell dysfunction is associated with several vascular diseases, such as arteriosclerosis (Verma et al., 2004) , stroke and aneurysms (Kadoglou and Liapis, 2004) , as well as tumoral angiogenesis and metastasis (Ranieri and Gasparini, 2001) . Dysregulation of growth plate chondrogenesis can result in dwarfism and skeletal abnormalities (Mundlos and Olsen, 1997) . Similarly, defects in negative selection can lead to autoimmune and lymphoproliferative syndromes (Sarvetnick and Ohashi, 2003; Siggs et al., 2006) . It is now essential to establish whether alterations of the class IIa HDAC-MEF2 axis occur in these human pathologies. Genetic alterations of MEF2 family members have been linked to cardiovascular diseases (Wang, 2005; Visvikis-Siest and Marteau, 2006) and acute lymphoblastic leukemia (Yuki et al., 2004; Prima et al., 2005) . Similarly, alterations of MEF2 transcriptional activity have been implicated in neurodegenerative disorders (Camins et al., 2006) and cardiac hypertrophy (Czubryt and Olson, 2004) .
Therapeutic intervention may be envisioned at a variety of points along the MEF2-HDAC pathway, the first one being modulation of class IIa HDAC enzymatic activity. In recent years, molecules inhibiting deacetylase activity of HDACs have generated a lot of interest as potential antitumors agents. This led to the development of a plethora of HDAC inhibitors that are now being tested in clinical trials for cancer and lymphoproliferative disorders (Bolden et al., 2006) . Now that class IIa HDACs have been established as key modulators in several important developmental processes, the use of such inhibitors may also be considered to modulate the physiological pathways controlled by these enzymes. For instance, HDAC inhibitors may be used to promote bone formation in dwarfism associated with several skeletal dysplasias, or prevent vascularization during tumor metastasis. One caveat of this option is the lack of specificity of the known HDAC inhibitors toward the various human HDACs. Most of the inhibitors against zinc-dependent enzymes to date target class I and class II HDACs rather nonselectively. Despite extensive efforts, development of class IIa HDAC-specific inhibitors has remained unsuccessful and thus specific targeting of each class IIa HDAC isoform may prove to be a hard goal to reach.
The current model predicts that suppression of class IIa HDAC nuclear export will prevent pathologic expression of MEF2-regulated genes. This could be achieved by preventing signal-induced phosphorylation of class IIa HDACs. In this context, the use of small molecule inhibitors targeting the known class IIa HDAC kinases is an attractive approach. However, this option could be complicated by the functional redundancy that exists between the various families (for example, CaMKs to PKDs to Marks to SIK1) and between the members of the same family (for example, PKD1 to PKD2 to PKD3, Mark2 to Mark3, CaMKI to CaMKII to CaMKIV). Nevertheless, the recent finding that HDAC4 is uniquely phosphorylated by CaMKII suggests that there might be some specificity in the regulation of class IIa HDACs by phosphorylation . Because class IIa HDAC kinases take part in other important cellular functions, it will be important to test potential side effects of these compounds.
Any alteration of the equilibrium between the activities of cognate phosphatases and kinases would likely affect the subcellular distribution and thus biological functions of class IIa HDACs. Our most recent findings indicate that interaction with 14-3-3 proteins protects class IIa HDACs from dephosphorylation (Martin and Dequiedt, submitted) . Identification of druglike molecules that displace this interaction would promote access of the phosphatases and consequently tip the balance toward hypophosphorylation and increased repression of MEF2-dependent transcriptional activity. Because 14-3-3, PP2A and myosin phosphatase are all involved in important biological functions, it is essential that the inhibitor be highly specific for the 14-3-3/class IIa HDACs interaction.
Conclusions and perspective
In the past few years, much has been learned about class IIa HDACs. Multiple interacting partners, involved in the association of class IIa HDACs with multienzymatic complexes, targeting to specific promoters or subcellular localization have been identified. Studies in transgenic and knockout mice have given fundamental insights into Class IIa histone deacetylases M Martin et al their regulation and biological functions. Despite these significant advances several essential questions remain unanswered. The growing list of interacting partners suggests numerous putative transcriptional targets for class IIa HDACs. However, to date, the biologically relevant targets of class IIa HDACs have remained, for the great part, MEF2-dependent promoters. Large-scale studies should be undertaken to identify MEF2-independent genes that could be regulated by class IIa HDACs. With the view to developing specific inhibitors for therapeutic purposes, it will be important to fully elucidate the mechanism, regulation and specificity of their deacetylase activity. Whereas the cytoplasmic localization of class IIa HDACs is thought to participate in their inactivation, it could also suggest a specific role for class IIa HDACs in the cytoplasm. This interesting issue deserves to be addressed. Finally, further analysis of class IIa HDAC regulation will not only improve our understanding of several fundamental processes for which they are key regulators, but will also provide invaluable new therapeutic perspectives for numerous human pathologies.
